Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte–colony-stimulating factor mobilization therapy
Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte–colony-stimulating factor mobilization therapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte–colony-stimulating factor mobilization therapy have?
Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte–colony-stimulating factor mobilization therapy has 61 citations in the OpenAlex counts ScholarIQ stores.
When was Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte–colony-stimulating factor mobilization therapy published?
Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte–colony-stimulating factor mobilization therapy has 2008 year in the ScholarIQ index.
What is the open-access status of Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte–colony-stimulating factor mobilization therapy?
Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte–colony-stimulating factor mobilization therapy has closed oa status in the ScholarIQ index.
What is the DOI of Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte–colony-stimulating factor mobilization therapy?
The DOI for Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte–colony-stimulating factor mobilization therapy is on the source record.
What is the PMID of Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte–colony-stimulating factor mobilization therapy?
The PMID for Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte–colony-stimulating factor mobilization therapy is on the source record.
What is the OpenAlex record for Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte–colony-stimulating factor mobilization therapy?
The OpenAlex for Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte–colony-stimulating factor mobilization therapy is on the source record.